Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
19.99
+2.19 (12.30%)
At close: Aug 13, 2025, 4:00 PM
18.76
-1.23 (-6.15%)
Pre-market: Aug 14, 2025, 9:05 AM EDT
Arrowhead Pharmaceuticals Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$43.14
Upside
+115.81%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +200.15% | Aug 11, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $40 → $38 | Buy | Maintains | $40 → $38 | +90.10% | Aug 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +300.20% | May 20, 2025 |
| Citigroup | Citigroup | Hold Maintains $21 → $17 | Hold | Maintains | $21 → $17 | -14.96% | May 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +200.15% | May 13, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $51 → $38 | Strong Buy | Reiterates | $51 → $38 | +90.10% | Feb 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +300.20% | Feb 12, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $42 | Buy | Reiterates | $42 | +110.11% | Feb 11, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +200.15% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +300.20% | Jan 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +300.20% | Dec 20, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +200.15% | Dec 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $80 | Strong Buy | Maintains | $60 → $80 | +300.20% | Dec 3, 2024 |
| Bernstein | Bernstein | Hold Maintains $27 → $24 | Hold | Maintains | $27 → $24 | +20.06% | Nov 29, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $62 → $45 | Buy | Maintains | $62 → $45 | +125.11% | Nov 27, 2024 |
| Citigroup | Citigroup | Hold Maintains $27 → $26 | Hold | Maintains | $27 → $26 | +30.07% | Nov 27, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.